Zobrazeno 1 - 4
of 4
pro vyhledávání: '"John C. Maffeo"'
Autor:
F. Johannes P. van Valenberg, Antoine G. van der Heijden, Christopher J. Cutie, Sumeet Bhanvadia, Kirk A. Keegan, Shalaka Hampras, Hussein Sweiti, John C. Maffeo, Shu Jin, Albert Chau, Donald L. Reynolds, Crysti Iarossi, April Kelley, Xiang Li, Katharine A. Stromberg, J.P. Michiel Sedelaar, Jessica J.O. Steenbruggen, Diederik M. Somford, J. Alfred Witjes
Publikováno v:
European Urology Open Science, Vol 62, Iss , Pp 8-15 (2024)
Background and objective: Patients with intermediate-risk non–muscle-invasive bladder cancer (IR NMIBC) have a high risk of recurrence and need effective therapies to reduce the risk of disease recurrence or progression. This phase 1b study (NCT027
Externí odkaz:
https://doaj.org/article/d2cd291b695348ec8a7437420c222d46
Autor:
Mark D. Tyson, David Morris, Juan Palou, Oscar Rodriguez, Maria Carmen Mir, Rian J. Dickstein, Félix Guerrero-Ramos, Kristen R. Scarpato, Jason M. Hafron, Edward M. Messing, Christopher J. Cutie, John C. Maffeo, Bradley Raybold, Albert Chau, Katharine A. Stromberg, Kirk A. Keegan
Publikováno v:
Journal of Urology. 209:890-900
Autor:
Mark D. Tyson, David Morris, Juan Palou, Oscar Rodriguez, Maria Carmen Mir, Rian J. Dickstein, Félix Guerrero-Ramos, Kristen R. Scarpato, Jason M. Hafron, Edward M. Messing, Christopher J. Cutie, John C. Maffeo, Bradley Raybold, Albert Chau, Katharine A. Stromberg, Kirk A. Keegan
Publikováno v:
Journal of Urology. 209:900-900
Autor:
Siamak Daneshmand, Iris S.G. Brummelhuis, Kamal S. Pohar, Gary D. Steinberg, Manju Aron, Christopher J. Cutie, Kirk A. Keegan, John C. Maffeo, Donald L. Reynolds, Bradley Raybold, Albert Chau, J. Alfred Witjes
Publikováno v:
Urologic Oncology-Seminars and Original Investigations, 40, 344.e1-344.e9
Urologic Oncology-Seminars and Original Investigations, 40, 7, pp. 344.e1-344.e9
Urologic Oncology-Seminars and Original Investigations, 40, 7, pp. 344.e1-344.e9
Contains fulltext : 251844.pdf (Publisher’s version ) (Open Access) OBJECTIVES: Neoadjuvant chemotherapy and radical cystectomy (RC) are underutilized standards of care for the treatment of muscle-invasive bladder cancer (MIBC) due to high patient